Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Lenvatinib in Rollover Patients
NCT03477175Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of lenvatinib in solid tumor, sponsored by Eisai Co., Ltd.. Started Aug 2018; status: completed.
02
Drugs
lenvatinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03477175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477175.